The last couple of months were marked with many collaborations with our partners and we've got some interesting upcoming events as well. 

The Norwegian Cancer Society: influencing national and international health and social policy

The Norwegian Cancer Society (NCS) is Norway’s largest cancer society and a member of UICC since 1949. NCS joined our Champions Programme in 2011, showing early leadership in driving the global advocacy agenda in the lead-up to the UN High-Level Meeting on NCDs. With their annual contribution of USD 100,000 to support UICC’s global advocacy campaign, they are making an impact far beyond their national borders. By involving other leading cancer organisations and working together, we have ensured key decision-makers hear our advocacy messages and we have achieved important tangible results.

As a leading Vanguard partner, the NCS is an active member in UICC’s high-level events convening cancer leaders. The NCS participated in key working groups convened by UICC and the NCD Alliance in advance of and after the 2011 UN Summit, including the European WHO consultations for Non-Communicable Diseases and the World Health Assembly panel discussions and the UICC Global Roundtable discussions.

The NCS has unique expertise in tobacco control, and has been leading this area on the international stage with support from UICC. In this context, the NCS represented UICC at the 2012 World Tobacco Conference in Singapore helping UICC members to coordinate activities on tobacco control. In March 2013, the NCS has demonstrated again its leadership launching a European branch of the McCabe Law Centre in Oslo.

UICC is proud to work closely with the Norwegian Cancer Society now and into the future!


UICC members and partners were present at the Global Roundtable Series – “Understanding and Curing Prostate Cancer: Important Issues, Patient Knowledge, and Support for Prostate Cancer Research”

On 4 April 2013, the University of Texas MD Anderson Cancer Center (MDACC) and UICC organised a global roundtable that brought together a selected group of academic researchers, patient advocates, biotechnology industry leaders, UICC members and partners to address key topics in prostate cancer treatment and research. 

Professor Mary Gospodarowicz, UICC President, moderated the event and was joined by a diverse mix of colleagues from member organisations including MDACC, American Cancer Society, King Hussein Cancer Center and Prostate Cancer Foundation of Australia; as well as corporate leadership from IBM, Sanofi, Varian, Panacea, Astellas and Bayer.

The report from the event is available online at


We are hosting an invite-only roundtable on 11 June in Geneva, bringing together UICC members, IARC and selected guests to discuss opportunities to accelerate capacity building and outputs of cancer registries in low- and middle-income countries - with a special focus on Africa.  If you are interested in attending this, please contact


We are delighted to announce that in recent weeks, Novartis has pledged a commitment to UICC’s “Together We Are Stronger” campaign over the next three years – ensuring support for our core advocacy and convening activities. UICC and Novartis have a strong history of 15 years of successful collaboration which dates back to 1997. We are thankful for their support and look forward to working together into the future.

As we embark on a continued intense period of advocacy on behalf of the cancer community in the lead up to the World Health Assembly, we encourage UICC members to become part of our Champions Programme, which help support the core work of UICC on behalf of its members around the world. We are proud to highlight that out of our 42 partners, 16 are UICC members. We consider partnerships to be fundamental to our success and we are keen to work closely with our members to coordinate expertise and resources in our advocacy efforts and to address inequity in the global cancer continuum.

We would love the opportunity to tell you more about how we work in partnership and to learn about your organisations’ interests and priorities. To arrange a meeting, please contact Lorena Framis, External Relations and Business Development Manager at: / +41 (0) 22 809 18 06